Skip to content

Enhancement of Pressure Healing With Pulsatile Lavage

Enhancement of Pressure Healing With Pulsatile Lavage

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00047619
Enrollment
28
Registered
2002-10-10
Start date
2002-06-30
Completion date
2008-05-31
Last updated
2015-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injury

Keywords

Decubitus Ulcers, Pulsatile Lavage, SCI, Spinal Cord Injury, Wound healing, pressure ulcer

Brief summary

The purpose of this study is to investigate the use of pulsatile lavage to enhance the healing of pressure ulcers in individuals with spinal cord injury (SCI). The goals will be achieved using a repeated-measures double-blinded randomized controlled study of individuals with SCI who have pelvic region pressure ulcers. A total of 60 subjects will be recruited to this study. Participants will be randomly assigned to a treatment or control group. Pulsatile lavage treatment will be administered to the treatment group daily for a 3 week period. The control group subjects will receive daily sham pulsatile lavage treatment for 3 weeks. All subjects will be monitored for a 3 week period and will continue to receive routine pressure ulcer care, i.e. dressings and bedrest with a regular turning regime during their participation in the study. All study participants will be monitored following the study period until complete closure of the pressure ulcer is achieved in order to determine total interval to final closure, including any surgical procedures required. In addition, the economic effects of pulsatile lavage treatment will be evaluated through monitoring of data collected in the Computerized Patient Record System (CPRS), including duration of admission, duration of total bedrest order and duration of treatment for pressure ulcer. This data will give an initial measure of the cost benefits that may be achieved with the use of pulsatile lavage for the treatment of pressure ulcers. Subjects will be recruited from the Louis Stokes Cleveland Veterans Affairs Medical Center (CVAMC). All individuals with spinal cord injury who are admitted to the SCI Unit with pelvic region pressure ulcers will be considered eligible for this study. Further selection criteria will be employed to screen potential participants as described below. On recruitment subjects will be randomly assigned to 2 groups of 20 subjects. The assessment methods employed will be the same for each volunteer. One group will participate in the pulsatile lavage intervention, the second group will act as controls.

Detailed description

The purpose of this study is to investigate the use of pulsatile lavage to enhance the healing of pressure ulcers in individuals with spinal cord injury (SCI). It will investigate the hypothesis that the treatment of non-necrotic pressure ulcers with pulsatile lavage will enhance the rate of healing. These goals will be achieved using a repeated-measures double-blinded randomized controlled study of individuals with SCI who have pelvic region pressure ulcers. A total of 60 subjects will be recruited to this study. Participants will be randomly assigned to a treatment or control group. Pulsatile lavage treatment will be administered to the treatment group daily for a 3 week period. The control group subjects will receive daily sham pulsatile lavage treatment for 3 weeks. All subjects will be monitored for a 3 week period and will continue to receive routine pressure ulcer care, i.e. dressings and bedrest with a regular turning regime during their participation in the study. All study participants will be monitored following the study period until complete closure of the pressure ulcer is achieved in order to determine total interval to final closure, including any surgical procedures required. In addition, the economic effects of pulsatile lavage treatment will be evaluated through monitoring of data collected in CPRS, including duration of admission, duration of total bedrest order and duration of treatment for pressure ulcer. This data will give an initial measure of the cost benefits that may be achieved with the use of pulsatile lavage for the treatment of pressure ulcers. Methodology Eligible individuals with SCI who are admitted to CVAMC with pelvic region pressure ulcers will be assigned to a pulsatile lavage treatment group or to a second non-intervention control group. A comprehensive assessment methodology will be employed to characterize pressure ulcer healing. All study participants will be assessed at routine intervals using objective measurement techniques. Statistical analysis of inter-group differences will allow the efficacy of pulsatile lavage for pressure ulcer healing to be established. Forty subjects will be enrolled in the study. Patient Selection Criteria: Subjects will be recruited from the Louis Stokes Cleveland Veterans Affairs Medical Center (CVAMC). All individuals with spinal cord injury who are admitted to the SCI Unit with pelvic region pressure ulcers will be considered eligible for this study. Further selection criteria will be employed to screen potential participants as described below. On recruitment subjects will be randomly assigned to 2 groups of 20 subjects. The assessment methods employed will be the same for each volunteer. One group will participate in the pulsatile lavage intervention, the second group will act as controls.

Interventions

PROCEDUREPulsatile Lavage

pulsatile lavage to wound bed

OTHERsham pulsatile lavage

pulsatile lavage to not directed at wound or patient

Sponsors

US Department of Veterans Affairs
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Spinal Cord Injury

Exclusion criteria

systemic disease

Design outcomes

Primary

MeasureTime frameDescription
Pressure Ulcer Geometrystudy participation - up to 6 weeksLinear assessment of wounds
Pressure Ulcer Volume Measurementstudy participation - up to 6 weeksVolume of pressure ulcer was measured by the amount of fluid that could be used to fill the pressure ulcer which was covered by an occlusive dressing

Countries

United States

Participant flow

Participants by arm

ArmCount
Pulsatile Lavage Group
pulsatile lavage therapy Pulsatile Lavage: pulsatile lavage to wound bed
14
Sham Lavage Group
sham pulsatile lavage sham pulsatile lavage: pulsatile lavage not directed at wound or patient
14
Total28

Baseline characteristics

CharacteristicPulsatile Lavage GroupSham Lavage GroupTotal
Age, Customized
Number of subjects >=18 years
14 participants14 participants28 participants
Sex/Gender, Customized
male gender
14 participants14 participants28 participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 140 / 14
serious
Total, serious adverse events
0 / 140 / 14

Outcome results

Primary

Pressure Ulcer Geometry

Linear assessment of wounds

Time frame: study participation - up to 6 weeks

ArmMeasureGroupValue (MEAN)
Pulsatile Lavage GroupPressure Ulcer GeometryLength in cm3.5 cm
Pulsatile Lavage GroupPressure Ulcer GeometryWidth in cm2.9 cm
Pulsatile Lavage GroupPressure Ulcer GeometryDepth in cm1.4 cm
Sham Lavage GroupPressure Ulcer GeometryLength in cm4.9 cm
Sham Lavage GroupPressure Ulcer GeometryWidth in cm3.0 cm
Sham Lavage GroupPressure Ulcer GeometryDepth in cm2.5 cm
Primary

Pressure Ulcer Volume Measurement

Volume of pressure ulcer was measured by the amount of fluid that could be used to fill the pressure ulcer which was covered by an occlusive dressing

Time frame: study participation - up to 6 weeks

ArmMeasureValue (MEAN)
Pulsatile Lavage GroupPressure Ulcer Volume Measurement5.8 cm^3
Sham Lavage GroupPressure Ulcer Volume Measurement12.4 cm^3

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026